Carcinoma ex pleomorphic adenoma: a case report and review of literature by Khanna, Deepak et al.
Carcinoma ex pleomorphic adenoma:  a case report and review of  literature
Deepak Khanna1, Tanay Chaubal2, Ranjeet Bapat2, Anshad Mohamed Abdulla3, 
Sunil Thomas Philip4, Suraj Arora5
1. Department of  Head, neck and oncology, D.Y.Patil University School of  medicine, Nerul, Navi Mumbai, 
    Maharashtra state, India, Zip code – 400706.
2. Division of  Clinical Dentistry, School of  Dentistry, International Medical University, Kuala Lumpur, Malaysia, 
    Zip code – 57000.
3. Department of  Pediatric dentistry and Orthodontic Sciences, King Khalid University, Abha, Kingdom of  
    Saudi Arabia, Pincode- 61471.
4. Department of  Pedodontics and Preventive Dentistry, Noorul Islam College of  Dental Sciences, 
    Trivandrum, Kerala, India
5. Department of  Restorative Dentistry, King Khalid University, Abha, Kingdom of  Saudi Arabia, Pincode- 61471.
 
E-mails:
Deepak Khanna - dkmaxfax@gmail.com; Tanay Chaubal – tanayvc@gmail.com; Ranjeet Bapat - 
ranjeetbapat@gmail.com; Anshad Mohamed Abdulla- anshad2004@gmail.com; Sunil Thomas Philip- 
rubysunildr@rediffmail.com; Suraj Arora- surajarorasgrd@yahoo.co.in
 
Abstract:
Background: Carcinoma ex pleomorphic adenoma (CA-ex-PA) is extremely unusual in minor salivary glands of  oral cavity. CA-
ex-PA is a carcinomatous change as a primary or as a recurrence of  pleomorphic adenoma.
Objective: Due to resemblance of  clinical symptoms of  Ca ex PA and benign pleomorphic adenoma, it is mandatory for sur-
geons to keep high degree of  clinical alertness, considering the peculiarity of  this tumor.
Case Report: 54-year-old male presented with swelling on left side in the pre-auricular region from the middle of  zygomatic 
arch to mastoid process and from tragus of  the ear up to angle of  mandible. Fine needle aspiration cytology revealed a mixture 
of  benign and malignant components. Total left parotidectomy with left radical neck dissection followed by reconstruction with 
cervicodeltopectoral flap was performed. Combination of  chemotherapy and radiotherapy were given to patient. Histologic 
examination and pre-operative fine needle aspiration cytology confirmed the diagnosis of  Carcinoma ex pleomorphic adenoma 
(CA-ex-PA). Two-year follow-up of  patient showed no recurrence of  the lesion.
Conclusion: Due to the similarity in the clinical symptoms of  CA-ex-PA and benign pleomorphic adenoma, it is vital that cli-
nicians maintain a high degree of  clinical vigilance, considering the oddity of  this malignancy.
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Introduction
Malignancies of  parotid gland are relatively rare and ac-
count for 1-3 % of  all tumors of  head.1 The most com-
mon benign salivary gland tumour is Pleomorphic ade-
noma (PA). It is mostly found in parotid glands and is 
usually managed successfully by surgical resection.2 Un-
fortunately around 6% of  these tumours transform into 
Carcinoma ex pleomorphic adenoma. (Ca-ex-PA).2,3 
Ca-ex-PA is defined as a carcinoma originating from a 
primary (de novo) or recurrent benign pleomorphic ade-
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noma.4 Its incidence is about 5 to 25% of  parotid carci-
nomas.5 The exact pathogenesis of  Ca-ex-PA is not clear. 
One school of  thought is that they are malignant from 
the onset whereas some believe it to be a carcinomatous 
transformation of  a mixed tumor.6 Histopathological ex-
aminations is important aid diagnosis. The objective in 
presenting this particular case is to present pathological 
and clinical features of  Ca-ex-PA.
Case report
A 54-year-old male patient reported to our institution 
with a swelling on left side of  the pre-auricular region 
extending anteroposteriorly from midpart of  zygomatic 
arch to mastoid process and superoinferiorly from tragus 
of  the ear to the angle of  mandible (Figure 1). 
 
Fig.1 Carcinoma ex Pleomorphic  
adenoma of left parotid gland 
The patient also had enlarged level IIB lymph nodes. The 
skin over the swelling was fixed; on palpation, the lesion 
was hard and firm in consistency. Intra-orally, the uvula 
and tonsil were shifted towards the right side. Fine needle 
aspiration cytology showed combination of  cells having 
benign and malignant elements (Figure 2); benign epi-
thelial component appeared as small to round cells with 
bland oval nuclei while malignant component appeared as 
large cells with large pleomorphic nuclei showing granu-
lar chromatin and high nucleus: cytoplasmic ratio (Figure 
3). 
Fluorodeoxyglucose (FDG) positron emission tomogra-
phy depicted a high uptake in the left parotid region and 
in the neck nodes at level IIB, III and IV. Ultrasonog-
raphy of  neck was done for mapping of  nodes which 
showed metastatic disease at level IIB and III. Treatment 
decision taken in our case was total parotidectomy of  the 
left side with left radical neck dissection followed by cer-
vicodeltopectoral flap (Figure 4). 
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Fig.2 FNAC showing cellular smear with clusters of benign  
(white arrow) and malignant cells (black arrow) –PAP stain 10 X 
 
 
 
Fig. 3 FNAC showing large cells with large pleomorphic nuclei  
having coarse chromatin- PAP stain – 40X (white arrow) 
 
 
Fig.4 Intraoperative view of Parotidectomy  
and radical neck surgery 
Most crucial part of  management was resectibility of  the 
lymph nodes as they were totally fixed on vital structures 
like common carotid artery and for that particular reason 
radical neck dissection was carried out first. Fixed skin 
over the lymph node was marked separately and upper 
cervical incision was joined to the marked skin. Second 
incision was a vertical incision which was dropped from 
primary incision at 90 degrees to 1-1.5 cm above clavicle 
sub-platsymal flaps were raised till identification of  great-
er auricular nerve. Clearance was done from level IA to 
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IB till level V, nodes at level IIB were completely fixed to 
the carotid sheath however a plane could be formed over 
the carotid sheath to remove the nodes, Level IIB nodes 
were excised in total with overlying skin. XI nerve, SCM 
was sacrificed. Once radical neck dissection was finished 
primary tumor was approached with a lazy S pre-auricu-
lar  (Blair’s incision), flap was raised in subplatsymal plane 
anteriorly till anterior border of  paroitd gland. Dissection 
was deepened in pre-auricular  tragus region for identi-
fication of  facial nerve main trunk which could not be 
found so dissection was continued till the styloid process 
posteriorly, medially tumor was free from posterior bor-
der of  ramus of  mandible so it was not sacrificed how-
ever of  the deep portion of  gland and base of  skull were 
blunt dissection was done with a gloved finger. Exter-
nal carotid artery was ligated at deeper level to medial 
surface of  deep lobe of  parotid gland and whole tumor 
was removed in toto. Cervicodeltopectoral flap marking 
was done by extending lower vertical incision till tip of  
acromion process of  scapula continuing inferomedially 
towards xiphisternum medial to nipple of  chest. 
Haemostasis was achieved and no.16 drains were placed 
and suturing done in layers patient healed uneventfully, 
drains removed after 12 days. Patient was sent for ad-
juvant radiotherapy and chemotherapy with a boost of  
radiation at level IIB. Histopathology of  the resected tu-
mor revealed undifferentiated carcinoma ex pleomorphic 
adenoma suggested by pleomorphic tumor cells with 
focally vacuolated cytoplasm seen infiltrating into the 
benign pleomorphic adenoma. Foci showing infiltrating 
carcinoma composed of  cells arranged in nests, sheets, 
cords and vague glandular pattern noted (Figure 5). His-
topathological examination showed areas of  pleomor-
phic adenoma composed of  biphasic population of  cells 
in chondromyxoid matrix. Duct like structures lined by 
inner epithelial and outer myoepithelial cells (Figure 6). 
 
 
Fig.5 Areas of pleomorphic adenoma (Black arrow)  
with infiltrating foci of carcinoma (grey arrow) – H&E stain-10 X 
 
 
 
Fig 6: Pleomorphic adenoma composed of biphasic population  
of cells in chondromyxoid matrix-H&E stain-10 X 
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The cells are highly pleomorphic with moderate amount 
of  eosinophilic cytoplasm, round nuclei with irregular 
nuclear borders, coarsely clumped chromatin with some 
showing prominent nucleoli (Figure 7). Post-operative 
immunohistochemistry and fluorescence in situ hybrid-
ization for HMGA-2 gene was positive (Figure 8). Recall 
after 24 months showed the absence of  any recurrence 
(Figure 9). The overall picture was suggestive of  Carcino-
ma ex pleomorphic adenoma (CA-ex-PA).
 
 
Fig 7: Foci of carcinoma composed of pleomorphic  
cells arranged in nests and vague glandular pattern- H & E stain-40 X 
 
 
 
Fig. 8: Immunostain for HMGA-2 gene 
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Fig 9: 24 months’ postoperative view without  
any recurrence of the lesion 
Discussion
CA-ex-PA known carcinoma in a mixed tumour or carci-
noma ex mixed tumour typically found in the gland aris-
ing from pleomorphic adenoma.7 CA-ex-PA encompass 
about 6.2% of  all mixed tumors,3.6% of  all tumors of  
salivary glands salivary tumors,12% of  all salivary malig-
nancies.(4) CA-ex-PA which is an uncommon malignant 
tumor of  salivary gland, has a prevalence rate of  5.6% 
cases/100,000 malignant tumors. The incidence rate of  
CA-ex-PA is  0.17% tumors/1 million persons.8
Livolsi.V and Perzin.K in 1977 introduced the term 
non-invasive carcinoma ex pleomorphic adenoma and 
concept of  malignant tumour arising in mixed tumour.9 
This was supported by Spiro et al., but with the observa-
tion that histological indications demonstrate pre-existing 
salivary gland tumour. CA-ex-PA is a carcinomatous con-
version inside a primary (de novo) or recurrent pleomor-
phic adenoma.
CA-ex-PA is mostly observed as a firm mass present 
in parotid gland. It has also been found to originate in 
sub-mandibular gland and at times in minor salivary 
glands in the region of  hard and soft palate.10 Tumors at 
these sites are smaller in size compared to those arising 
from the major salivary glands. CA-ex-PA have also been 
identified in lacrimal glands, nasal cavities, trachea and 
breast.11–14  Literature on CA-ex-PA in different areas 
of  head and neck region are added in a tabulated format 
indicating area of  carcinoma, case reported with relevant 
information (Table 1).
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Table 1: Review of literature of CA-ex-PA 
Author/year Area of Carcinoma Case Reported Reference 
Felix A et al 2002 Parotid Gland Non-invasive Carcinoma ex Pleomorphic adenoma of malignant nature showing cervical lymph node 
metastasis on the same side of the lesion 
15 
Ethunandan et al 2006 Parotid Gland Four cases of Carcinoma ex Pleomorphic adenoma showed atypical histologic features; out of which one 
case exhibited benign vascular invasion and the other three exhibited malignant dysplastic features 
suggestive of carcinoma without evidence of extra-capsular invasion.  
16 
Tomoaki Mori et al 2010 Parotid Gland Three cases of Non-invasive Carcinoma ex Pleomorphic adenoma showing features of an adenocarcinoma 
not otherwise specified. 
17 
Chooback et al 2017 Parotid Gland A case of Carcinoma ex Pleomorphic adenoma of the left parotid gland. The histologic features were 
supportive of malignant transformation showing predominantly sarcomatoid features. 
The patient received multiple systemic therapy for locally recurrent lesion. 
 
2 
Rossi et al 2014 Parotid Gland Carcinoma ex pleomorphic adenoma metastasizing to the spleen. Both regional lymphatic and 
distant haematogenous 
spread were identified. 
18 
Buva KB et al 2017 Sub-mandibular Gland A case of non-invasive carcinoma ex pleomorphic adenoma. Benign part consisted of myxomatous area 
with partial capsule and neoplastic cells showed invasion into capsule. 
19 
Sharmila PS et al 2015 Parotid Gland A case of carcinoma ex pleomorphic adenoma where malignant component exhibited mucoepidermoid 
differentiation. 
20 
Matsushima M et al 2012 Sub-mandibular Gland The case report described a carcinoma ex pleomorphic adenoma of the sub-mandibular area exhibiting 
renal metastasis. 
21 
Mohan S et al 2015 Parotid Gland A rare case of non-invasive carcinoma ex pleomorphic adenoma exhibiting ossification in the tumour. 22 
Vahedi M et al 2016 Buccal Minor Salivary 
Gland 
A rare case of carcinoma ex pleomorphic adenoma reported on buccal minor salivary gland. Author 
suggested that in case of small and non-invasive carcinoma ex pleomorphic adenoma. Surgical excision is 
the treatment of choice. 
23 
Adagio E et al 2017 Lacrimal Gland Carcinoma ex pleomorphic adenoma with epithelial and myoepithelial differentiation of left lacrimal gland 
showing decreased vision, compressive optic neuropathy. The patient underwent radiation therapy and 
remains free of clinical or radiographic disease 24 months following surgery 
24 
Ariyoshi Y et al 2012 Sublingual gland A case of carcinoma ex pleomorphic adenoma of a sublingual gland in Treatment carried out was excision 
of the mass with the sublingual salivary gland in an en bloc fashion via an intraoral approach. 
Histopathologic picture showed rupture of fibrous capsule and diffuse cell-rich sheets composed of 
myoepithelial cells with round nuclei. Immunohistochemically, the cells that composed of cell rich sheets 
were positive to smooth muscle actin. 
25 
Sedassari BT et al 2014 Palatal minor salivary 
gland 
A case of palatal minor salivary gland Carcinoma ex pleomorphic adenoma composed of invasive 
micropapillary salivary duct carcinoma and adenoid cystic carcinoma components with multiple nodal 
metastases. Neoplastic cells showed heterogeneous immunohistochemical profile with both luminal and 
myoepithelial differentiation. The invasive micropapillary salivary duct carcinoma component 
demonstrated overexpression of the oncoprotein human epidermal growth factor receptor-2. 
26 
Chen HH et al 2010 Soft Palate minor 
salivary gland 
A case of soft palatal mass progressing to left cheek numbness, proptosis. Biopsy of soft palatal tumor 
revealed pleomorphic adenoma. Magnetic resonance imaging showed a tumor involving left maxilla 
extending from pterygopalatine fossa, inferior orbital fissure to cavernous sinus. Excision of tumor 
revealed Carcinoma ex pleomorphic adenoma with adjuvant concomitant chemo-radiation therapy. 
27 
Liao PW et al 2016 Minor salivary gland of 
nasal cavity 
An unusual case of pedunculated intranasal Carcinoma ex pleomorphic adenoma wherein a wide 
endoscopic excision was carried out with no recurrence. 
28 
Sakamoto Y  et al 2017 Minor salivary gland of 
the tongue 
A case of carcinoma ex pleomorphic adenoma of right dorsum of tongue with a history of breast 
carcinoma. Macroscopic examination revealed an oval tumor with a smooth mucosal surface of 10mm in 
diameter in the right dorsum of tongue.  Histologic examination revealed carcinoma ex pleomorphic 
adenoma. Treatment undertaken was partial glossectomy. 
  
29 
  
Onur Ismı et al 2015 Sub-mandibular region 
apart from sub-
mandibular gland 
A rare case of carcinoma ex pleomorphic adenoma of neck. Histopathological examination revealed an 
intracapsular malign tumor composed of both myoepithelial and epithelial components in a lobular pattern 
close to parotid gland. Treatment rendered was total excision of the mass. 
30 
Goyal P et al 2016 Minor salivary gland of 
buccal mucosa 
This case report describes a carcinoma ex pleomorphic adenoma of the buccal mucosa which was 
dissected and excised. It’s a diagnostic challenge at such locations. 
 31 
  
Mitate E. et al 2013 Minor salivary gland of 
upper lip 
A rare case of carcinoma ex pleomorphic adenoma located on upper lip Tumor was removed and 
histologic revealed well-demarcated tumor tissues showing typical histologic features of pleomorphic 
adenoma and mitotic figures in central area of tumor tissue suggestive of squamous cell carcinoma. 
32 
Sreedharan S et al 2012 Maxillary sinus A rare case of carcinoma ex pleomorphic adenoma in maxillary sinus with histopathological examination 
and management. 
33 
  
CA-ex-PA has more predilection for females compared 
to males and is frequently seen during sixth to seventh 
decade of  life.34,35 Based on extent of  carcinomatous 
component outside the fibrous capsule, CA-ex-PA can 
be sub-classified as i) non-invasive ii) minimally invasive 
(<1.5 mm penetration of  malignant element into extra-
capsular tissue) and, iii) invasive (greater than 1.5 mm inva-
sion from tumor capsule into to neighbouring tissues).36,37  
Invasive type has non-defined infiltrative margins.  There 
is very high nuclear pleomorphism with prominent nu-
cleoli. There is adjacent perivascular and perineural in-
filtration with haemorrhagic and necrotic foci. Where as 
in Non-invasive type has well-defined borders with very 
little pleomorphic nuclei. Small quantity of  myxoid area 
is seen. Mix of  Cellular and acellular areas are observed 
in low foci. As per the histological results, our case is an 
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example of  invasive type. As per WHO classification 
published in 2005 for malignant changes of  pleomorphic 
adenoma, CA-ex-PA is the one which is most frequent-
ly encountered in comparison to metastasizing PA and 
carcinosarcoma.27  In our case, four important clues to 
arrive at a diagnosis were 1) location of  swelling in the 
parotid region, 2) Fine needle aspiration cytology show-
ing mixture of  benign and malignant cells 3) Fluorodeox-
yglucose (FDG) positron emission tomography showed 
an increased uptake in left parotid region, neck and 4) 
Ultra-sonography of  neck for mapping of  lymph nodes 
showing metastasis. On this basis, we arrived at the diag-
nosis of  Carcinoma ex pleomorphic adenoma.  Adjuvant 
pre-treatment fine needle aspiration cytology, fluorode-
oxyglucose (FDG) positron emission tomography and 
ultrasonography aid in making preliminary diagnosis and 
extent of  metastasis. Pre-operative diagnosis of  tumor of  
parotid gland is established on basis of  history, clinical 
findings, FNA findings, histologipicture. FNAC is fre-
quently used preoperatively for diagnosis of  CA-ex-PA. 
The sensitivity is still low mainly associated with error in 
sampling4, cytomorphological variability and less experi-
ence. Lesions salivary glands with suspected carcinoma, it 
is important to have aspiration from multiple sites. CA-
ex-PA can be misdiagnosed as some other malignant sali-
vary gland tumor or mistaken with PA. Abundant atypical 
cells, coarsely clumped chromatin with prominent nu-
cleoli and necrosis are key features in distinguishing PA 
from malignant tumors including CA-ex-PA.
In majority of  cases of  PA, most common malignancy 
observed is adenocarcinoma NOS (not otherwise speci-
fied). The other unusual malignancies which can be seen 
in relation to PA are that can arise in setting of  PA are 
myoepithelial carcinoma ,adenosquamous carcinoma, un-
differentiated carcinoma ,adenoid cystic carcinoma and 
sarcomatoid carcinoma.35,38 In our case, it was adenocar-
cinoma NOS developing in setting of  PA.
Treatment often involves a surgical procedure(parotidec-
tomy), which may be followed by radiotherapy.  Superficial 
parotidectomy is done in cases of  minimally invasive CA-
ex-PA whereas complete or radical parotidectomy is done 
for frankly invasive CA-ex-PA. A related neck dissection 
is also undertaken if  cervical lymph nodes presents with 
evidence of  metastases. Neck dissection may be function-
al, modified, or radical as per the indications. The surgical 
technique to eliminate the neoplasm could be followed by 
reconstructive surgery. A soft tissue reconstruction like 
radial free flap or a cervical rotation flap is accomplished 
in various cases for repair of  the defect. In our case the 
reconstruction was facilitated by cervico-deltopectoral 
flap. Patients can be given with options of  combination 
of  chemotherapy and radiotherapy. Post-operative radio-
therapy is normally used in cases of  high grade disease 
or questionable resection adequacy, and for invasion of  
perineural tissues and lymph nodes.39 in this case, both 
radiotherapy and chemotherapy with a boost of  radiation 
at level IIB was given as per the treatment plan. Multiple 
factors like type of  invasion, lymph node and local or 
distant metastasis, tumor grade and size and total removal 
of  tumor does dictate prognosis of  CA-ex-PA.34,36 Sur-
vival rates of  these patients may be increased by prefect 
diagnosis of  CA-ex-PA along with complete surgical and 
radiological treatment of  these patients.36
Recent molecular investigations of  CA-ex-PA has provid-
ed with new insights on its carcinogenesis. It is seen that 
there is a progressive loss of  heterozygosity (LOH) at 
chromosomal arms 8q, 12q, and 17p.40  Role of  p53 gene 
has been suspected in pathogenesis of  CA-ex-PA. Righi 
et al first reported with point mutation of  p53 in CA-ex-
PA.41 Patel et al found better immunohistochemical stain-
ing for p16 proteins and cyclin D1 with malignant com-
ponents of  CA-ex-PA compared to normal stromal and 
epithelial components.42 Also with progression of  CA-
ex-PA  ,  expression of  p21 gene may increase , linking to 
its role in progression of  disease.43 Levels of  COX-2 are 
sufficiently lower in PA compared to CA-ex-PA sugges-
tive of  increased expression of  COX-2 could be an rele-
vant as an early stage event in the pathogenesis of  the this 
disease.44 Epidermal growth factor receptor (EGFR)44, 
HGF-A (scatter factor) and c-Met (a proto-oncogene) 
(45), Transforming growth factor alpha (TGF α)44, Fibro-
blast growth factors (FGF)-2 45 have been investigated 
to have a role in progression and invasion of  CA-ex-PA. 
There was increased expression of   E-cadherin expres-
sion in cases of  CA-ex-PA with comparatively less re-
activity in comparison to benign tumours.46 Thus, along 
with clinical, histological findings, these specific candidate 
genes which have been associated with the development 
and progression of  CA-ex-PA should be considered as a 
vital diagnostic aid for confirmation of  lesion.
Conclusion
Ca ex PA is an uncommon aggressive malignancy. Quite 
often it is associated with regional metastasis which invari-
ably leads to mortality. It also poses a difficulty in diag-
nosis, as the mixed tumour component is usually minute 
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and is easily overlooked, and the malignant component 
may be difficult to classify.1  Preoperative diagnosis of  
salivary gland tumours is quite challenging because of  the 
overlap in histopathological characteristics. Due to the 
similarity of  clinical symptoms of  Ca ex PA and benign 
pleomorphic adenoma, it is vital that clinicians maintain 
a high degree of  clinical vigilance, considering the oddity 
of  this malignancy and performs postoperative immuno-
histochemistry and fluorescence in situ hybridization for 
HMGA-2 gene to confirm the diagnosis. In conclusion, 
early and prompt diagnosis followed by aggressive surgi-
cal intervention of  patients with Carcinoma ex pleomor-
phic adenoma can enhance their survival rates.
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